Related Experiment Video
Updated: Apr 16, 2026

06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
1.4K
Association between macrophage migration inhibitory factor rs1007888 and GDM
1Department of Obstetrics, Affiliated Hospital of Qingdao University, Qingdao, China yingzhancn@126.com.
Genetics and Molecular Research : GMR
|March 3, 2015
Summary
The macrophage migration inhibitory factor (MIF) rs1007888 GG genotype is linked to increased genetic susceptibility for gestational diabetes mellitus (GDM). This finding highlights MIF polymorphism
Area of Science:
- Genetics
- Endocrinology
- Obstetrics
Background:
- Gestational diabetes mellitus (GDM) poses risks to maternal and fetal health.
- Genetic factors play a role in GDM susceptibility.
- Macrophage migration inhibitory factor (MIF) is implicated in inflammatory and metabolic processes.
Purpose of the Study:
- To investigate the association between MIF rs1007888 single-nucleotide polymorphisms (SNPs) and GDM genetic susceptibility.
- To analyze the relationship between MIF rs1007888 genotypes and key metabolic parameters in pregnant women.
Main Methods:
- Case-control study involving 240 GDM patients and 330 healthy pregnant women.
- Genotyping of MIF rs1007888 polymorphism.
- Comparison of genotype/allele frequencies and metabolic markers (fasting blood glucose, insulin, HOMA-IR, HOMA-b).
Main Results:
- Significant differences in MIF rs1007888 genotype distribution between GDM and control groups (P < 0.05).
- No significant difference in allele frequencies (P > 0.05).
- The GG genotype was associated with higher fasting blood glucose, insulin, HOMA-IR, and lower HOMA-b levels compared to GA and AA genotypes (P < 0.05).
Conclusions:
- MIF rs1007888 polymorphism is associated with insulin resistance and pancreatic β-cell function in GDM.
- The GG genotype of MIF rs1007888 may represent a genetic susceptibility factor for GDM development.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
5.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
Pathophysiology of Diabetes
4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Diabetes Mellitus: Overview and Type I Subtype
6.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.4K
Glucose Transporters
28.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.5K
Pharmacogenomics: Identification of New Drug Targets
95
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
95
Diabetes: Symptoms, Diagnosis, and Complications
2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K

